Drug Profile
Research programme: hepatic inflammation therapeutics - Cytoguide
Alternative Names: Cymac-001Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Cytoguide
- Class Antibodies; Fluorinated steroids; Glucocorticoids; Immunoconjugates; Pregnadienediols
- Mechanism of Action Glucocorticoid receptor agonists; Immunosuppressants; Macrophage stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Non-alcoholic steatohepatitis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Non-alcoholic-steatohepatitis in Denmark (Parenteral)
- 09 Oct 2012 Preclinical trials in Non-alcoholic steatohepatitis in Denmark (Parenteral)